SCHEMBL7464943

SCHEMBL7464943

COC1=CCc2cnc(Nc3ccc(N4CCN(CC(C)C(N)C=O)CC4)cc3)nc2C1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.39
KDR P35968 1/20 0.39
BRD4 O60885 3/20 0.38
CDK4 P11802 8/20 0.38
CCND1 P24385 7/20 0.38
CDK2 P24941 5/20 0.38
CDK1 P06493 4/20 0.38
CCNE1 P24864 4/20 0.38
CCNB1 P14635 3/20 0.38
SYK P43405 1/20 0.38
JAK2 O60674 1/20 0.37
AURKA O14965 1/20 0.37
FGFR4 P22455 3/20 0.37
RPS6KA6 Q9UK32 1/20 0.36
CCND2 P30279 2/20 0.36
CCND3 P30281 2/20 0.36
CCNB2 O95067 1/20 0.36
CCNE2 O96020 1/20 0.36
FGFR1 P11362 1/20 0.36
CCNA2 P20248 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7469986 0.90 EGFR (0.38) EGFRKDRBRD4CDK4CCND1
SCHEMBL7467084 0.89 JAK3 (0.38) EGFRKDRCDK4CCND1CDK2
SCHEMBL7476134 0.88 CDK4 (0.40) EGFRKDRBRD4CDK4CCND1
SCHEMBL7472695 0.87 EGFR (0.42) EGFRKDRBRD4CDK4CCND1
SCHEMBL7463398 0.87 EGFR (0.42) EGFRKDRBRD4CDK4CCND1
SCHEMBL7473002 0.86 EGFR (0.43) EGFRKDRBRD4CDK4CCND1
SCHEMBL6087469 0.83 CDK4 (0.51) EGFRKDRBRD4CDK4CCND1
SCHEMBL6087559 0.82 CDK2 (0.44) EGFRKDRCDK4CCND1CDK2
SCHEMBL6087447 0.81 CDK2 (0.58) CDK4CCND1CDK2CDK1CCNE1
SCHEMBL6086302 0.81 CDK4 (0.56) CDK4CCND1CDK2CCNE1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed